Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).
about
Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1Recent developments in receptor tyrosine kinases targeted anticancer therapyFunctions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathyRole of targeted therapy in metastatic colorectal cancerIdentification of novel isoforms of activin receptor-like kinase 7 (ALK7) generated by alternative splicing and expression of ALK7 and its ligand, Nodal, in human placentaVascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxiaBlood vessels as targets in tumor therapyInfectious spleen and kidney necrosis virus ORF48R functions as a new viral vascular endothelial growth factor.Fluorescence and Bioluminescence Imaging of Angiogenesis in Flk1-Nano-lantern Transgenic Mice.Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration.Effects of maternal serum on permeability of glomerular endothelial cell membrane.Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors.Expression and purification of functional human vascular endothelial growth factor-a121; the most important angiogenesis factor.VEGF-mediated fusion in the generation of uniluminal vascular spheroidsPregnancy-induced hypertension and preeclampsia: levels of angiogenic factors in malaysian womenDisrupted balance of angiogenic and antiangiogenic signalings in preeclampsia.Double anti-angiogenic and anti-inflammatory protein Valpha targeting VEGF-A and TNF-alpha in retinopathy and psoriasis.Variable promoter methylation contributes to differential expression of key genes in human placenta-derived venous and arterial endothelial cells.Vascular endothelial growth factor receptor family genes: when did the three genes phylogenetically segregate?Therapies directed at vascular endothelial growth factor.The role of VEGF in normal and neoplastic hematopoiesis.Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells.Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study.Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancyContext-based resolution of semantic conflicts in biological pathwaysVascular endothelial growth factor receptor 1 morpholino decreases angiogenesis in a murine corneal suture model.A VEGFR1 antagonistic peptide inhibits tumor growth and metastasis through VEGFR1-PI3K-AKT signaling pathway inhibition.The potential role of vascular endothelial growth factor in the central nervous system.Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolinDecreased VEGF expression and microvascular density, but increased HIF-1 and 2α accumulation and EPO expression in chronic moderate hyperoxia in the mouse brainVariations in the vascular endothelial growth factor pathway predict pulmonary complicationsVEGF/VEGFR signalling as a target for inhibiting angiogenesis.Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy.Pathophysiology of tumor neovascularization.Using angiogenic factors and their soluble receptors to predict organ dysfunction in patients with disseminated intravascular coagulation associated with severe traumaAngiogenic factors and their soluble receptors predict organ dysfunction and mortality in post-cardiac arrest syndromeA prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.
P2860
Q24805363-7422C0ED-B51D-465F-BE1B-EEDE90DE073BQ26751331-E5F0301B-7AB3-4E35-90BA-BE8CEA226FFFQ26824541-94909DBE-3AAB-49E0-B539-7FDCA69390FAQ28068817-3B543547-0808-4FA6-9928-8E0A1337BBBAQ28212233-772B7906-CCCE-43DB-8135-0DB4AB500242Q28469224-5DE236B0-289D-47F9-8D00-2FEF730813D6Q28572517-9DE241E2-2291-4BF0-9242-925E36BB15A2Q28590737-1592D968-E3F0-4F8D-B1CE-101E049C9CF6Q30367977-0708BDDB-CD90-4542-9F10-179EC886715BQ30846397-1E4FF6AB-185F-4C0C-96FE-1FBFF230F3F5Q33739306-9EB7614E-2D1D-4CD0-BA96-454C39C3748FQ33825219-CF469A88-0F95-43F9-8F61-58390601F55BQ33961186-30E02845-DF0C-43CC-8B88-B3BAE5042174Q34030193-FF439D3B-57F7-4D5E-9F59-9858E0CC4309Q34063852-AEA01F4B-5EDA-47C2-B771-8ABFFDD2F5B2Q34150126-8D0E6E51-8FDB-47AF-83ED-D80851B08814Q34255236-ADE67F5B-3A11-4CBE-A0A2-DA37918A6D39Q34731047-F3812FCD-7460-4DC8-823E-A7B7DD250B53Q34800330-FFEC8DBA-DCB3-4E0F-9BA2-6D43BD7A2DDFQ34820879-06657EAA-0DEB-45C4-8854-BFDADF08C92FQ35009293-0D75F8F1-B080-42AD-9521-33036238401DQ35011885-21B6623C-B4BF-4696-A5A7-23503A93608CQ35052515-A3CBE842-3DC0-48B6-9519-1CD2744B7D20Q35546629-CB5D46E2-E141-4BC5-BBEF-3D9AA0B7F527Q35567173-92FB36F5-E38A-4006-B521-CC74274E243AQ35609359-BF30308D-3688-4195-AD88-CA13557757B8Q35647966-7827A810-C287-497A-9D0A-CCA9D1782B9AQ35653287-F863098F-E61A-4C83-9A48-9C5F62C8CC41Q35865416-AEACF509-732F-429D-BE3C-DF41D38FD3F0Q35875146-260D1DFD-B4AB-4566-9907-F7FE271F8427Q35939261-EF51A366-51DA-4655-8351-6B1A51D73F00Q36048718-8BF2B31F-7B52-4FB9-A3CA-0CE31B132008Q36266605-B564985B-27D7-4003-A569-5B07206A3EE3Q36303003-F9CA1690-2023-4A51-87F8-00A4EF380643Q36677407-6EF0EC66-A122-4089-A43A-9E45DECE13D2Q36691776-67423397-B6D6-4E2F-960A-684DD50075CCQ36742274-F2294358-D905-4DA6-A31D-E098074936B4Q36925848-555A8810-833F-4B99-BB38-8384A97F5068Q36928129-4899AD6E-CBA4-4ECA-B8FF-1E8E4A30AA92Q37083956-6C73B055-EC55-401C-9E44-58F02537ABDB
P2860
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).
@ast
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).
@en
Structure and dual function of vascular endothelial growth factor receptor-1
@nl
type
label
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).
@ast
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).
@en
Structure and dual function of vascular endothelial growth factor receptor-1
@nl
prefLabel
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).
@ast
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).
@en
Structure and dual function of vascular endothelial growth factor receptor-1
@nl
P1476
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).
@en
P2093
P304
P356
10.1016/S1357-2725(01)00026-7
P577
2001-04-01T00:00:00Z